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Background-—Aspeciﬁc scoring systems are used to predict the risk of death postsurgery in patients with infective endocarditis
(IE). The purpose of the present study was both to analyze the risk factors for in-hospital death, which complicates surgery for IE,
and to create a mortality risk score based on the results of this analysis.
Methods and Results-—Outcomes of 361 consecutive patients (mean age, 59.115.4 years) who had undergone surgery for IE in
8 European centers of cardiac surgery were recorded prospectively, and a risk factor analysis (multivariable logistic regression) for
in-hospital death was performed. The discriminatory power of a new predictive scoring system was assessed with the receiver
operating characteristic curve analysis. Score validation procedures were carried out. Fifty-six (15.5%) patients died postsurgery.
BMI >27 kg/m2 (odds ratio [OR], 1.79; P=0.049), estimated glomerular ﬁltration rate <50 mL/min (OR, 3.52; P<0.0001), New
York Heart Association class IV (OR, 2.11; P=0.024), systolic pulmonary artery pressure >55 mm Hg (OR, 1.78; P=0.032), and
critical state (OR, 2.37; P=0.017) were independent predictors of in-hospital death. A scoring system was devised to predict in-
hospital death postsurgery for IE (area under the receiver operating characteristic curve, 0.780; 95% CI, 0.734–0.822). The score
performed better than 5 of 6 scoring systems for in-hospital death after cardiac surgery that were considered.
Conclusions-—A simple scoring system based on risk factors for in-hospital death was speciﬁcally created to predict mortality risk
postsurgery in patients with IE. ( J Am Heart Assoc. 2017;6:e004806. DOI: 10.1161/JAHA.116.004806.)
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O utcome in patients with infective endocarditis (IE) is acomplex process, mediated by the immune system, and
a function of interactions between patient-related factors (eg,
demographic data, risk factors for cardiovascular disease,
underlying cardiac disease, and comorbidities) and the
properties of the causal agent (eg, nature, virulence, and
antibiotic resistance). In 25% to 30% of cases, medical
treatment alone is inadequate and must be combined with
surgery, which aims to control infection by debridement and
removal of necrotic tissue, and to restore cardiac morphology
by surgical repair and/or valve replacement. Cardiac opera-
tions in some of these critically ill patients may be challenging
and yield poor early and late results, even when carefully
performed. Mortality rates have been reported to range
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between 10% in elective patients and up to 30% in urgent
surgery. Prolonged invasive ventilation, low cardiac output,
acute kidney injury, sepsis, and bleeding are frequent
postoperative complications.1–3 Consequently, for patients
with IE, risk stratiﬁcation is important not only for the surgeon
for decision making, but also for counseling of the patient and
comparative assessment of quality of care.
Currently, the risk of mortality postsurgery for IE is
estimated using predictive scoring systems that have been
derived from patient databases where most of the patients
had had cardiac operations other than those for endocardi-
tis.4–7 Because of this inherent limitation, the utility of these
aspeciﬁc predictive systems for patients with IE has been
called into question.8–13 In fact, speciﬁc scores to predict in-
hospital death postsurgery in patients with IE have also been
devised,14–16 but with no external validation, and their impact
in clinical practice is unclear.
In this context, we performed a prospective, population-
based observational study in 8 European centers of cardiac
surgery. The aims of the study were both to analyze the risk
factors for hospital death and create a risk score based on the
results of this analysis.
Methods
Study Patients
The study population consisted of 361 patients who under-
went surgery for IE: (1) 138 consecutive patients (mean age,
60.68.5 years; 19.6% females) who were operated on
between 2000 and 2015 at the Cardiovascular Department
of the University Hospital of Trieste, Trieste, Italy; (2) 223
consecutive patients (mean age, 58.215.6 years; 22%
females) who underwent surgery in 2008 in 7 French
administrative areas: greater Paris, Lorraine, Rho^ne-Alpes,
Franche-Comte, Marne, Ille-et-Vilaine, and Languedoc-
Roussillon. The adult population in these areas (15.3 million
inhabitants) covers 31.9% of the overall French population
aged >18 years.11 The French centers are grouped in the
Association for the study and prevention of IE (Association
pour l’Etude et la Prevention de l’Endocadite Infectieuse;
AEPEI). Since 2001, the members of the AEPEI (see Appendix
for full list of members) are enrolling patients with IE in each
of the French administrative areas in an ad-hoc prospective
registry.17 In 2008, the data collection was particularly
exhaustive, comprehensive, and accurate because it coin-
cided with an epidemiological study performed by the AEPEI
to update national data regarding the epidemiology of IE in
France. Only deﬁnite cases of IE, as deﬁned by the modiﬁed
Duke criteria,18 were included into the present study. For all
patients, baseline characteristics, surgical and endocarditis-
related features, as well as postoperative complications were
prospectively recorded in a computerized data registry. For
each center, approval to conduct the study was acquired from
the local ethics committee. Patients were informed about the
study, but were not required to provide individual consent, in
accord with French and Italian legislation.
A risk factor analysis for in-hospital death postsurgery for
IE was performed and a predictive scoring system, named the
AEPEI score, was devised from the results of the analysis.
External validation was performed using data from the AEPEI
registry of patients with deﬁnite IE who underwent surgery
between 2001 and 2015. The validation sample comprised
161 AEPEI patients for whom there were sufﬁcient data to
calculate the AEPEI score. The 223 AEPEI patients operated
on in 2008 and included in the present study had been
excluded preventively from the validation sample.
Deﬁnitions
Unless otherwise stated, the deﬁnitions and cut-off values of
the preoperative variables were those used for the European
System for Cardiac Operative Risk Evaluation (EuroSCORE). In
particular, critical state was deﬁned as the presence of
ventricular tachycardia/ventricular ﬁbrillation or aborted
sudden death, preoperative cardiac massage, preoperative
ventilation before anesthetic room, preoperative inotropes or
intra-aortic balloon pump, and preoperative acute renal failure
(anuria or oliguria <10 mL/h).5,6 Myocardial infarction (MI)
was deﬁned according to the recent deﬁnition criteria of type
V MI by Moussa et al.19 Acute kidney injury was deﬁned as an
increase in serum creatinine of 1.5 to 1.9 times the baseline
level or serum creatinine increase ≥26.5 lmol/L within
7 days postsurgery.20 Sternal wound infections were graded
according to the Centers for Disease Control and Prevention
deﬁnitions of surgical site infections. In brief, superﬁcial
incisional infection involves only skin or subcutaneous
tissues, deep incisional infection involves deep soft tissues
(fascial and muscle layers) with or without the sternal bone,
and organ/space infection involves the mediastinum (medi-
astinitis).21 For the purposes of this study, deep incisional
infection and mediastinitis were considered to be deep sternal
wound infections. Any sternal wound infection occurring
within 3 months postsurgery was considered as postopera-
tive wound infection.
Statistical Analysis
Continuous variables with normal distribution are expressed
as meanSD and those without normal distribution as median
[interquartile range]. Categorical variables are expressed as
number and percentage. Statistical comparison of baseline
characteristics was performed using Pearson’s chi-square or
Fisher’s exact test for categorical variables, and Student t test
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or the Mann–Whitney U test for continuous variables.
Backward step-wise multivariable logistic regression analysis
was used to identify independent predictors of in-hospital
mortality. All variables with a P<0.1 by univariable analysis
were included in the multivariable model. For each variable,
the odds ratio (OR) and the corresponding 95% CI were
calculated. Each of the risk indices had the variable weighted
according to its regression coefﬁcient. Goodness of ﬁt of the
model was evaluated with the Hosmer–Lemeshow test. The
discriminatory power of the model was assessed with the
receiver operating characteristic (ROC) curve and the calcu-
lation of the area under the curve (AUC). The new predictive
scoring system, the AEPEI score, was compared (using De
Long’s method) with 3 existing scoring systems for in-hospital
mortality after cardiac surgery, namely the EuroSCORE II,5 the
logistic EuroSCORE,16 and the Ontario Province Risk (OPR)
score,17 as well as with 3 existing scores speciﬁcally designed
to predict early mortality postsurgery for IE, namely the
PALSUSE score (the prosthetic valve, age ≥70, large
Table 1. Baseline Characteristics of Patients (n=361)*
Variable
Trieste
Database
(n=138)
AEPEI
Registry
(n=223) P Value
Age, y 60.68.5 58.215.6 0.15
Female sex 27 (19.6) 49 (22.0) 0.58
Hypertension 21 (15.2) 90 (40.4) <0.0001
Current smoker 11 (8) 54 (24.2) <0.0001
BMI, kg/m2 25.54.1 25.45.4 0.88
Diabetes mellitus 22 (15.9) 48 (21.5) 0.19
Diabetes mellitus on
insulin
9 (6.5) 18 (8.1) 0.58
Anemia† 113 (81.9) 171 (76.6) 0.95
White blood cell, 103/mm3 125.9 14.910.5 0.0032
CRP, mg/L 193.681.3 140.485.5 <0.0001
Poor mobility‡ 2 (1.4) 18 (8.1) 0.0075
Chronic lung disease‡ 13 (9.4) 20 (9.0) 0.88
eGFR, mL/min§ 67.737.3 69.435.4 0.67
Dialysis 13 (9.4) 2 (0.9) <0.0001
Extracardiac arteriopathy‡ 22 (15.9) 28 (12.6) 0.36
NYHA class IV 55 (39.9) 81 (36.3) 0.5
CCS class 4 20 (14.5) 3 (1.3) <0.0001
Recent MI‡ 0 1 (0.4) 1
Left ventricular ejection
fraction <50%‡
32 (23.2) 43 (19.3) 0.37
sPAP >55 mm Hg‡ 3 (2.2) 15 (12.4) 0.053
Coronary artery disease 18 (13) 25 (18.1) 0.6
Previous cardiac surgery 37 (26.8) 17 (7.6) <0.0001
Critical state‡ 27 (19.6) 35 (15.7) 0.34
Length of the preoperative
hospital stay (days)k
6 [2–19] 13 [5–25] 0.16
CCS indicates Canadian Cardiovascular Society; CRP, C-reactive protein; eGFR,
estimated glomerular ﬁltration rate; EuroSCORE, European System for Cardiac
Operative Risk Evaluation; MI, myocardial infarction; NYHA, New York Heart
Association; ROC, receiver operating characteristic; sPAP, systolic pulmonary artery
pressure.
*Unless otherwise stated, values are meanSD, or number (percentage).
†
Deﬁned as haemoglobin <12 g/dL for women and <13 g/dL for men.
‡
The deﬁnitions and the cut-off values are those used for the EuroSCORE II.5
§
The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was
used to estimate GFR.
k
Median [interquartile range].
Table 2. Surgical Features (n=361)*
Variable
Trieste
Database
(n=138)
AEPEI
Registry
(n=223) P Value
Reason for surgery
Refractory heart failure
attributed to valvular
dysfunction
32 (23.2) 59 (26.5) 0.49
Persistent infection 18 (13) 28 (12.6) 0.89
Embolism 58 (42) 106 (47.5) 0.31
Recurrent 4 (2.9) 49 (22) <0.0001
Perivalvular
complications†
40 (29) 67 (30) 0.82
Surgical priority‡ <0.0001
Elective 26 (18.8) 107 (48.0)
Urgent 90 (65.2) 94 (42.2)
Emergency 22 (15.9) 11 (4.9)
Salvage 0 11 (4.9)
Valve involvement
Aortic valve 86 (62.3) 138 (61.9) 0.93
Mitral valve 60 (43.5) 107 (48.0) 0.40
Tricuspid valve 7 (5.1) 28 (12.6) 0.02
Multivalvular 23 (16.7) 55 (24.7) 0.07
Large intracardiac
destruction§
57 (41.3) 119 (52) 0.08
Weight of the intervention‡
Combined CABG 25 (18.1) 13 (5.8) <0.0001
Single non-CABG 89 (64.5) 126 (56.5) 0.13
Two procedures 46 (33.3) 82 (36.8) 0.51
Three procedures 3 (2.2) 15 (6.7) 0.053
Surgery on thoracic aorta 9 (6.5) 15 (6.7) 0.94
CABG indicates coronary artery bypass grafting; EuroSCORE, European System for
Cardiac Operative Risk Evaluation.
*Number (percentage).
†
Perivalvular leak, annular or aortic abscess, sinus of Valsalva aneurysm, aortic ﬁstula,
and prosthetic valve detachment.
‡
The deﬁnitions are those used for the EuroSCORE II.5
§
Deﬁned as extensive valve destruction, perivalvular complications, or multivalvular
involvement.
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intracardiac destruction, Staphylococcus spp, urgent surgery,
sex [female], and EuroSCORE ≥10),18 the De Feo score (for
native valve IE),19 and the Society of Thoracic Surgeons (STS)
score for IE.20 Both internal validation, based on the 0.632
bootstrap method, and external validation were performed. In
addition, a new set of statistical analyses was carried out as
follows: (1) In order to verify the stability of the original 5-
variable model of the AEPEI score without the variable linked
to pulmonary artery pressure, an alternate model of the AEPEI
score was created by removing systolic pulmonary artery
pressure (sPAP) >55 mm Hg from the original set of variables
from which the score was generated. The goodness of ﬁt and
the discriminatory power of this alternate model were
measured. (2) Because all the variables of the AEPEI score
except BMI >27 kg/m2 were also components of the
EuroSCORE II, we added BMI >27 kg/m2 to EuroSCORE II
and investigated its incremental value with continuous net
reclassiﬁcation improvement and integrated discrimination
improvement measures.22 (3) Given the ratio of events to
potential predictor variables, Akaike’s information criterion
(AIC), which accounts for the small number of events relative
to the number of covariates, was analyzed.23 Statistical
analyses were performed using SPSS for Windows (version
13.0; SPSS, Inc, Chicago, IL).
Results
Italian Versus French Study Patients
There were some differences in baseline characteristics,
surgical data, and endocarditis-related features between the
Italian and French patients of the study. The rates of
preoperative dialysis, Canadian Cardiovascular Society (CCS)
class 4, previous cardiac surgery, urgent/emergency priority,
and combined coronary surgery were higher in Italian
patients, whereas poor mobility, recurrent embolism, and
active endocarditis were more frequent in French patients.
Baseline levels of C-reactive protein were higher in Italian
Table 3. Endocarditis-Related Features (n=361)*
Variable
Trieste Database
(n=138)
AEPEI Registry
(n=223) P Value
Endocarditis <0.0001
Active† 72 (52.2) 203 (91)
Treated† 66 (47.8) 20 (9.0)
Type of endocarditis
Native valve 103 (74.6) 182 (81.6) 0.78
Prosthetic valve 27 (19.6) 41 (18.3) 0.78
Intracardiac device or
other side
12 (8.7) 36 (16.1) 0.043
Causal agents 0.014
Streptococcus
species
45 (32.6) 89 (39.9)
Staphylococcus
aureus
23 (16.7) 49 (22)
Coagulase-negative
Staphylococci
10 (7.2) 23 (10.3)
Enterococcus species 13 (9.4) 24 (10.8)
Gram-negative
bacteria
6 (4.3) 9 (4)
Fungi 2 (1.4) 2 (0.9)
Not identified 39 (28.3) 27 (12.1)
EuroSCORE indicates European System for Cardiac Operative Risk Evaluation.
*Number (percentage).
†
The deﬁnitions are those used for the EuroSCORE II.5
Table 4. In-Hospital Mortality and Perioperative
Complications*
Complication n=361
In-hospital death 56 (15.5)
30-day death 42 (11.6)
Stroke 9 (2.5)
Prolonged (>48 hours) invasive ventilation 482 (22.7)
Pneumonia 30 (8.3)
Atrial fibrillation, new onset 38/358† (10.6)
MI19 2 (0.6)
Immediate reoperation for acute prosthetic failure 9 (2.5)
Low cardiac output‡ 32 (8.9)
Intraoperative and postoperative use of IABP 9 (2.5)
Use of ECMO 6 (1.7)
Acute kidney injury20 67 (18.6)
Renal replacement therapy 23 (6.4)
Bleeding peptic disease 4 (1.1)
Mesenteric ischemia 7 (1.9)
Acute pancreatitis 2 (0.6)
Multiorgan failure (3 or more organs) 11 (3.0)
Sepsis 22 (6.1)
Mediastinal re-exploration§ 38 (10.5)
Deep sternal wound infection21 10 (2.8)
Length of the postoperative hospital stay, days 23.9 [12.7–42.4]k
ECMO indicates extracorporeal membrane oxygenator; IABP, intra-aortic balloon
pumping; KDIGO, Kidney Disease: Improving Global Outcomes; MI, myocardial infarction.
*Unless otherwise stated, values are number (percentage).
†
Patients with preoperative stable sinus rhythm or paroxysmal atrial ﬁbrillation.
‡
Deﬁned as 3 consecutive cardiac index measurements <2.0 L/min per m2 despite
adequate preload, afterload and inotropic support, or IABP.
§
Through resternotomy or subxifoid window.
k
Median [interquartile range].
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patients (Tables 1 through 3). Overall, the expected operative
risk was higher in Italian patients than in the French series
(mean EuroSCORE II, 15.918.7% versus 9.93.6%;
P<0.0001). In-hospital mortality was higher in Italian than in
French patients (20.3% versus 12.6%; P=0.049); 30-day
mortality was also higher in the Italian series (18.1% versus
7.6%; P=0.0025).
Risk Factors for Hospital Death and Multivariable
Analysis Model
A total of 56 (15.5%) patients died in hospital after surgery
(Table 4). Baseline characteristics and operative data of these
patients and the corresponding endocarditis-related features
(Table S1) were compared with those of survivors of the in-
hospital phase postsurgery (Tables S2 through S4). Risk
factor analysis for in-hospital death postsurgery for IE was
performed. A multivariable model with 16 variables was
created using all the variables with a P<0.1 by univariable
analysis. BMI >27 kg/m2, estimated glomerular ﬁltration rate
(eGFR) <50 mL/min, New York Heart Association (NYHA)
class IV, sPAP >55 mm Hg, and critical state were found to
be independent predictors of postoperative in-hospital death
(Tables 5 and 6).
The AEPEI Score: Performance and Validation
By multivariable analysis (Table 5), a new scoring system, the
AEPEI score, was created to predict in-hospital mortality
postsurgery for IE (Table 6). The new score includes 5
variables and consists of 7 risk classes (Table 7); its
performance is summarized in Tables 8 and 9. In the study
population, the AEPEI score had equivalent discriminatory
power to that of the EuroSCORE II (P=0.4). It was found to be
better than the logistic EuroSCORE (P=0.0026) and OPR score
(P=0.065) and better than each of the 3 speciﬁc predictive
systems (De Feo score, P=0.054, PALSUSE score, P=0.047,
and STS risk score for IE; P=0.027), albeit without reaching
statistical signiﬁcance for the De Feo score (Figure 1). There
was no difference in performance of the AEPEI score between
Table 5. Risk Factor Analysis for In-Hospital Death After Surgery for IE (n=361)
Variable
Univariable
Analysis* Original Multivariable Analysis†
Alternate Multivariable
Analysis‡
P Value OR 95% CI P Value OR 95% CI P Value
Age >70 years 0.016 1.14 0.52 to 2.53 0.74 1.18 0.55 to 2.55 0.67
BMI >27 kg/m2§ 0.039 2.15 1.06 to 4.37 0.034 1.91 0.96 to 3.81 0.065
eGFR <50 mL/mink,¶ <0.0001 3.62 1.78 to 7.78 <0.0001 3.19 1.59 to 6.41 <0.0001
Dialysis 0.066 1.04 0.27 to 3.96 0.96 1.47 0.41 to 5.27 0.56
NYHA class IV 0.0001 2.43 1.14 to 5.18 0.022 2.07 1.00 to 4.27 0.05
CCS class 4 0.015 1.13 0.38 to 3.3 0.83 1.19 0.41 to 3.45 0.74
Left ventricular ejection fraction, 30% to 50%¶ 0.036 1.37 0.65 to 2.9 0.41 1.29 0.61 to 2.72 0.51
sPAP >55 mm Hg¶ 0.044 3.29 1.13 to 9.53 0.028   
Coronary artery disease 0.052 1.33 0.1 to 17.9 0.83 1.46 0.11 to 18.6 0.77
Previous cardiac surgery 0.022 1.29 0.48 to 3.48 0.61 1.30 0.50 to 3.38 0.59
Critical state¶ <0.0001 2.52 1.11 to 5.73 0.027 2.49 1.11 to 5.78 0.026
Length of the preoperative hospital stay <10 days§ 0.061 1.12 0.52 to 2.44 0.77 1.06 0.51 to 3.39 0.87
Urgent surgical priority¶ 0.006 1.62 0.76 to 3.47 0.21 1.80 0.84 to 3.83 0.13
Combined CABG 0.052 1.49 0.12 to 2.34 0.77 1.26 0.09 to 17.8 0.87
Surgery on thoracic aorta 0.075 2.44 0.69 to 8.67 0.17 2.55 0.78 to 8.31 0.12
Prosthetic valve endocarditis 0.043 1.49 0.61 to 6.34 0.38 1.45 0.61 to 3.45 0.4
CABG indicates coronary artery bypass grafting; CCS, Canadian Cardiovascular Society; eGFR, estimated glomerular ﬁltration rate; EuroSCORE, European System for Cardiac Operative
Risk Evaluation; NYHA, New York Heart Association; OR, odds ratio; ROC, receiver operating characteristic curve; sPAP, systolic pulmonary artery pressure.
*All the variables that were considered for the univariable analysis are listed in Table S1.
†
All variables with a P<0.1 by univariable analysis were included in the multivariable model.
‡
All variables with a P<0.1 by univariable analysis except sPAP >55 mm Hg were included in the multivariable model.
§
The best discriminative value for in-hospital mortality by ROC analysis.
k
The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was used to estimate GFR.
¶
The deﬁnitions and cut-off values are those used for EuroSCORE II.5
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the Italian and French series (P=0.37; Table 10). The logistic
equation of the AEPEI ﬁnal model was:
p ¼ e
ðb0þ
P
biXiÞ
1þ eðb0þ
P
biXiÞ
where b0 is the constant of the logistic regression equation (ie,
3.0645) and bi the coefﬁcient of the variable Xi. The
coefﬁcients and variable values are: for BMI, bi=0.58 and Xi=1
if BMI >27 kg/m2, or 0 if BMI ≤27 kg/m2; for eGFR, bi=1.26
and Xi=1if eGFR <50 mL/min, or 0 if eGFR ≥50 mL/min; for
NYHA class IV, bi=0.75 and Xi=1 in case of NYHA class IV, or
0 if not; for sPAP, bi=0.58 and Xi=1 if sPAP ≥55 mm Hg, or 0
if sPAP <55 mm Hg; for critical state, bi=0.86 and Xi=1 if the
patient is in critical state, or 0 if not (Table 6).
All the AEPEI score variables remained signiﬁcant by
bootstrap internal validation (Table 11). By external validation,
there were no signiﬁcant differences between expected and
observed deaths (v2=2.7; 5 df; P=0.75; Table 12) and the
discriminatory power of the score was conﬁrmed to be good
(AUC, 0.715; 95% CI, 0.638–0.783; Figure 2).
The Alternative 3-Variable AEPEI Score Model
According to the alternate multivariable model (Table 5), an
alternate model of the AEPEI score was created (Table 6). This
model includes 3 variables and consists of 4 risk classes
(Table 7). Its discriminatory power was equivalent to that of
the original 5-variable model (P=0.49); calibration was slightly
lower (Tables 8 and 13; Figure 3). There was no signiﬁcant
difference in the performance of the alternate model of the
AEPEI score between the Italian and the French series
(P=0.29; Table 10). The logistic equation of the alternate
AEPEI model was:
p ¼ e
ðb0þ
P
biXiÞ
1þ eðb0þ
P
biXiÞ
where b0 is the constant of the logistic regression equation (ie,
1.411) and bi the coefﬁcient of the variable Xi. The
coefﬁcients and variable values are: for eGFR, bi=1.32 and
Xi=1if eGFR <50 mL/min, or 0 if eGFR ≥50 mL/min; for
NYHA class IV, bi=0.75 and Xi=1 in case of NYHA class IV, or
0 if not; for critical state, bi=0.86 and Xi=1 if the patient is in
critical state, or 0 if not (Table 6).
The 3 variables of the alternate model of the AEPEI score
remained signiﬁcant by bootstrap internal validation
(Table 14). By external validation, there were no signiﬁcant
differences between expected and observed deaths (v2=2.1;
1 df; P=0.15; Table 15) and the discriminatory power of the
score was satisfactory (AUC, 0.690; 95% CI, 0.613–0.761).
The AEPEI Incremented EuroSCORE II
The variable BMI >27 kg/m2 was added to the EuroSCORE II.
The integrated discrimination improvement was 0.027
Table 6. The AEPEI Score: the Risk Factors for In-Hospital Death (by Backward Multivariable Logistic Regression) and the Scoring
(n=361)
Variable
The Original Model* The Alternate Model†
Regression
Coefﬁcient SE OR 95% CI P Value Points‡
Regression
Coefﬁcient SE OR 95% CI P Value Points‡
BMI >27 kg/m2§ 0.58 0.34 1.79 1.02 to
3.45
0.049 1      
eGFR <50 mL/
mink,¶
1.26 0.33 3.52 1.84 to
6.73
<0.0001 2.2 1.32 0.33 3.75 1.97 to
7.14
<0.0001 1.8
NYHA class IV 0.75 0.33 2.11 1.10 to
4.05
0.024 1.3 0.75 0.33 2.12 1.12 to
4.02
0.021 1
sPAP
>55 mm Hg¶
0.58 0.58 1.78 1.06 to
5.61
0.032 1      
Critical state¶ 0.86 0.36 2.37 1.16 to
4.82
0.017 1.5 0.85 0.36 2.35 1.17 to
4.74
0.017 1.1
Constant 3.065 1.411
eGFR indicates estimated glomerular ﬁltration rate; EuroSCORE, European System for Cardiac Operative Risk Evaluation; NYHA, New York Heart Association; ROC, receiver-operating
characteristic curve; sPAP, systolic pulmonary artery pressure.
*All variables with a P<0.05 by the original multivariable analysis (Table 5) were included.
†
All variables with a P<0.05 by the alternate multivariable analysis (Table 5) were included.
‡
Dividing each regression coefﬁcient by the lowest coefﬁcient and approximating to the ﬁrst decimal place.
§
The best discriminatory value for in-hospital mortality by ROC analysis.
k
The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was used to estimate GFR.
¶
The deﬁnitions and cut-off values are those used for EuroSCORE II.5
DOI: 10.1161/JAHA.116.004806 Journal of the American Heart Association 6
The AEPEI Score Gatti et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on July 21, 2017
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Table 7. Speciﬁc Predictive Scoring Systems for In-Hospital Mortality After Surgery for IE
Scoring
System Study Population Variables (Points)
Discrimination
Power Expected Hospital Mortality
AEPEI score,
the original
model*
(2016)
361 pts. (mean age,
59.115.4 years);
AEPEI registry (223 pts.,
7 French hospitals,
2008) & Cardiovascular
Department of Trieste,
Italy (138 pts., 2000–
2015);
Hospital mortality,
15.5%;
30-Day mortality, 11.6%
5 variables:
BMI >27 kg/m2 (1)
eGFR <50 mL/min (2.2)
NYHA class IV (1.3)
sPAP >55 mm Hg (1)
Critical state (1.5)
AUC, 0.780
(95% CI, 0.734
–0.822)
Score, 0 to 1 point: expected mortality,
4.5% to 7.7%;
Score, 1.3 to 2 points: expected mortality,
9% to 12.9%;
Score, 2.2 to 2.8 points: expected mortality,
14.1% to 18.9%;
Score, 3.2 to 3.8 points: expected mortality,
22.6% to 29.4%;
Score, 4.5 to 5 points: expected mortality,
38.2% to 45.1%;
Score, 5.5 to 6 points: expected mortality,
52.5% to 59.4%;
Score, 7 points: expected mortality, 72.4%
AEPEI score,
the
alternate
model*
(2016)
Idem 3 variables:
eGFR <50 mL/min (1.8)
NYHA class IV (1)
Critical state (1.1)
AUC, 0.774
(95% CI, 0.727
–0.816)
Score, 0 to 1 point: expected mortality,
19.6% to 34.1%;
Score, 1.1 to 1.8 points: expected mortality,
36.6% to 47.7%;
Score, 2.1 to 2.9 points: expected mortality,
55% to 68.3%;
Score, 3.9 points: expected mortality, 82%
PALSUSE
score14
(2014)
437 pts. (mean age,
61.415.5 years);
GAMES registry (26
Spanish hospitals,
2008–2010);
Hospital mortality,
24.3%
7 variables:
Prosthetic valve (2)
Age ≥70 years (1)
Large intracardiac destruction (2)
Staphylococcus spp (2)
Urgent surgery (2)
Sex, female (2)
EuroSCORE II ≥10% (1)
AUC, 0.84 (95%
CI, 0.79–0.88)
Hospital mortality ranged from 0, in patients
with score=0, to 45.4% in patients with
score >3
De Feo score
(for native
valve IE)15
(2012)
440 pts. (mean age,
4916 years);
Department of
Cardiothoracic Surgery
of Naples, Italy (1980–
2009);
Hospital mortality, 9.1%
6 variables:
Age, 5 classes (5–13)
Renal failure (5)
NYHA class IV (9)
Preop. ventilator support (11)
Positivity of latest preop. blood cultures (5)
Perivalvular involvement (5)
AUC, 0.88 (95%
CI, 0.82–0.93)
Score, 0 to 5 points: expected mortality
≤4.55%;
Score, 7 to 13 points: expected mortality,
4.55% to 9.1%;
Score, 14 to 19 points: expected mortality,
9.2% to 27.3%;
Score ≥20 points: expected mortality
>27.3%
STS risk
score for
IE16 (2011)
19 543 pts. (mean age,
55 years);
STS database (2002–
2008)
30-day mortality, 8.2%
12 variables:
Emergency, salvage status, or cardiogenic
shock (17)
Preop. hemodialysis, renal failure, or
creatinine level >2.0 mg/dL (12)
Preop. inotropic or balloon pump
support (10)
Active (vs treated) endocarditis (10)
Multiple valve involvement (9)
Insulin-dependent diabetes mellitus (8)
Arrhythmia (8)
Previous cardiac surgery (7)
Urgent status without cardiogenic shock (6)
Non-insulin-dependent diabetes mellitus (6)
Hypertension (5)
Chronic lung disease (5)
AUC, 0.758 
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse; AUC, area under the receiver operating characteristic (ROC) curve; eGFR, estimated glomerular
ﬁltration rate; EuroSCORE, European System for Cardiac Operative Risk Evaluation; GAMES, Grupo de Apoyo al Manejo de la Endocarditis infecciosa en ESpa~na; IE, infective endocarditis;
NYHA, New York Heart Association; PALSUSE, Prosthetic valve, Age ≥70, Large intracardiac destruction, Staphylococcus spp, Urgent surgery, Sex [female], EuroSCORE II ≥10%; Preop.,
preoperative; pts., patients; sPAP, systolic pulmonary artery pressure; STS, the Society of Thoracic Surgery.
*Table 6.
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(P<0.01). The continuous net reclassiﬁcation improvement
was 0.13 (P=0.37).
The AIC Analysis
With 56 events and 16 variables in the initial logistic
regression (with multiple categories that further increase
the dimension), the initial model was severely overﬁt
(Table 5). However, according to the AIC,22 each predictive
system that was considered in this study except EuroSCORE II
was <0.0001 times as probable as the AEPEI score to
minimize the information loss. The alternate AEPEI model was
0.0091 times as probable as the original AEPEI model to
minimize the information loss (Table 8).
Discussion
Based on analysis of perioperative data from 361 patients
from 8 European centers of cardiac surgery, we devised a
weighted scoring system to predict in-hospital mortality
postsurgery for IE, namely the AEPEI score. The score is
composed of only 5 variables and consists of 7 classes of risk.
It was derived from a backward step-wise logistic regression
model that was created to ﬁnd the independent predictors of
in-hospital death in this series of patients with IE. Although
the variables of the model were chosen from a pool of
baseline characteristics of the patients, surgical data, and
endocarditis-related features, all the variables of the AEPEI
score (BMI >27 kg/m2, eGFR <50 mL/min, NYHA class IV,
sPAP >55 mm Hg, and critical state) refer to the patient’s
preoperative state and include an anthropometric measure-
ment, a laboratory ﬁnding, an estimate of resting dyspnea, an
invasive (or ultrasound) intracardiac pressure measurement,
and a well-deﬁned composite variable of events indicating the
critical preoperative state of the patient.
The goodness of ﬁt of the statistical model was satisfac-
tory and the score showed a good discriminatory power. Both
internal and external validation of the AEPEI score were
performed. The results of the validation procedures conﬁrmed
satisfactory calibration and discriminatory power of the score.
In the study population, the AEPEI score performed better
than 3 speciﬁc scoring systems for in-hospital (or 30-day)
mortality postsurgery for IE that were considered18–20 and
was superior to 214,16 of the 3 scoring systems for in-hospital
(or 30-day) mortality after any cardiac operation that were
used for comparison. These results were conﬁrmed also
according to a more-robust approach such as the AIC.22 In
addition, the AEPEI score is not intended only for native valve
endocarditis, as is the De Feo score,15 and the AEPEI score
includes a composite variable, that is, critical state, similar to
what applies in the PALSUSE and STS risk scores for IE.18,20
The AEPEI score was found to be equivalent to EuroSCORE II,
which consists of 18 (simple and composite) variables and
was modeled from a contemporary surgical cohort of 22 381
patients, including 497 (2.2%) with active IE.5 The EuroSCORE
II performance in estimating perioperative risk of patients
Table 8. Performance of the AEPEI Score (2 Models) and of 6 Other Speciﬁc/Nonspeciﬁc Predictive Scoring Systems for In-
Hospital Mortality After Surgery for IE in the Original Series of Patients
System
Original Series (n=361)
Goodness of Fit* Discriminatory Power†
AIC Value23Chi-square DF P Value AUC 95% CI
Specific
AEPEI score, the original model 2.6 5 0.76 0.780 0.734 to 0.822 257.5
AEPEI score, the alternate model 3.9 3 0.27 0.774 0.727 to 0.816 266.9
PALSUSE score14 2.3 7 0.97 0.684 0.633 to 0.731 289.1
De Feo score (for native valve IE)15 2.8 6 0.9 0.722 0.654 to 0.790 296.8
STS risk score for IE16 7.9 8 0.44 0.709 0.659 to 0.756 300
Aspecific
EuroSCORE II5 9.5 8 0.3 0.751 0.704 to 0.795 132.5
Logistic EuroSCORE6 14.3 8 0.068 0.632 0.580 to 0.682 306.9
OPR score7 12.1 8 0.15 0.698 0.647 to 0.745 288.7
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse; AIC, Akaike’s information criterion; AUC, area under the receiver operating characteristic (ROC) curve;
DF, degrees of freedom; EuroSCORE, European System for Cardiac Operative Risk Evaluation; IE, infective endocarditis; NYHA, New York Heart Association; OPR, Ontario Province Risk;
PALSUSE, prosthetic valve, age ≥70, large intracardiac destruction, Staphylococcus spp, urgent surgery, sex (female), EuroSCORE II ≥10%; STS, the Society of Thoracic Surgeons.
*By the Hosmer–Lemeshow test for logistic regression.
†
By ROC analysis.
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undergoing surgery for IE has been evaluated by other
investigators. Some researchers think that it underestimates
post–cardiac surgery mortality in these patients7; others have
demonstrated poor calibration and comparatively poor dis-
crimination of the system for emergency cardiac surgery.8
Yet, others believe that the EuroSCORE II may be a useful and
appropriate tool for estimating perioperative risk, even for IE
patients, and that speciﬁc endocarditis features will increase
model complexity without an unequivocal improvement in
predictive ability.6,9 Consequently, there is a lack of consen-
sus on this issue. To improve the EuroSCORE II performance
in IE, we added the only variable present in the AEPEI score
that is not in the EuroSCORE II (namely, BMI >27 kg/m2).
Results showed that there was no added value to be derived
from adding this variable to EuroSCORE II. Logistic Euro-
SCORE showed a poor performance in the present study, even
though other researchers have reported different results.21
sPAP was the sole hemodynamic parameter that was
considered for analysis, which can be evaluated by echocar-
diography when even a trivial tricuspid regurgitation is
present. In the absence of any grade of tricuspid regurgitation,
the PAP measurement requires right heart catheterization.
The fact that this method is invasive and could be a port of
entry for infection make some practitioners reluctant to
perform it presurgery. We therefore created an alternate
model of the AEPEI score by removing sPAP >55 mm Hg from
the original set of variables on which the original score was
based. This procedure generated a 3-variable predictive
scoring system (eGFR <50 mL/min, NYHA class IV, and
Figure 1. The new predictive scoring system for in-hospital death postsurgery for IE (the AEPEI score) vs (A) three
scoring systems speciﬁcally created to predict in-hospital (or 30-day) mortality postsurgery for IE and (B) 3 predictive
scoring systems for in-hospital (or 30-day) mortality after cardiac surgery. AEPEI indicates Association pour l’Etude et
la Prevention de l’Endocadite Infectieuse; AUC, area under the receiver operating characteristic curve; EuroSCORE,
European System for Cardiac Operative Risk Evaluation; IE, infective endocarditis; OPR, Ontario Province Risk;
PALSUSE, Prosthetic valve, Age ≥70, Large intracardiac destruction, Staphylococcus spp, Urgent surgery, Sex [female],
EuroSCORE ≥10; STS, the Society of Thoracic Surgeons.
Table 9. The AEPEI Score, the Original Model: Contingency
Table for the Hosmer–Lemeshow Test for Logistic Regression
(n=361)
Group
Death Survival
TotalObserved Expected Observed Expected
1 4 5.2 113 111.8 117
2 2 3.2 39 37.8 41
3 5 4.5 45 45.5 50
4 7 4.5 26 28.5 33
5 7 8.0 33 32.0 40
6 11 10.2 26 26.8 37
7 20 20.4 23 22.6 43
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse.
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critical state) that had equivalent discriminatory power, but
lower goodness of ﬁt, compared to the original AEPEI score.
Unlike other predictive systems,14 no infectious agent was
related to an increased in-hospital mortality postsurgery.
However, in the present experience, there was an under-
representation of potentially catastrophic organisms, such as
Table 10. Performance of the Considered Predictive Scores in the Trieste Database and in the AEPEI Registry
System
Trieste Database (n=138) AEPEI Registry (n=223)
Goodness of Fit* Discriminatory Power† Goodness of Fit* Discriminatory Power†
Chi-square DF P Value AUC 95% CI Chi-square DF P Value AUC 95% CI
Specific
AEPEI score, the original model 12.6 6 0.55 0.744 0.662 to 0.814 4.5 5 0.49 0.804 0.746 to 0.854
AEPEI score, the alternate model 5.03 4 0.28 0.732 0.650 to 0.804 1.5 3 0.68 0.802 0.744 to 0.852
PALSUSE score14 3.4 7 0.85 0.723 0.640 to 0.795 6.3 7 0.5 0.691 0.626 to 0.751
De Feo score (for native valve IE)15 1.6 6 0.95 0.730 0.648 to 0.802 5.2 6 0.63 0.720 0.656 to 0.778
STS risk score for IE16 3.3 8 0.92 0.706 0.623 to 0.780 3.1 8 0.93 0.740 0.677 to 0.796
Aspecific
EuroSCORE II5 4.2 8 0.84 0.763 0.683 to 0.831 5.1 8 0.65 0.772 0.711 to 0.825
Logistic EuroSCORE6 15.5 8 0.05 0.658 0.572 to 0.736 13.8 8 0.088 0.500 0.433 to 0.568
OPR score7 13.8 8 0.087 0.637 0.551 to 0.717 3.9 8 0.87 0.694 0.656 to 0.753
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse; AUC, area under the receiver operating characteristic (ROC) curve; DF, degrees of freedom;
EuroSCORE, European System for Cardiac Operative Risk Evaluation; IE, infective endocarditis; NYHA, New York Heart Association; OPR, Ontario Province Risk; PALSUSE, prosthetic valve,
age ≥70, large intracardiac destruction, Staphylococcus spp, urgent surgery, sex (female), EuroSCORE II ≥10%; STS, The Society of Thoracic Surgeons.
*By the Hosmer–Lemeshow test for logistic regression.
†
By ROC analysis.
Table 11. Bootstrap Analysis of the Logistic Regression Model From Which the Original Model of the AEPEI Score was Generated*
Variable A
Bootstrap (No. of Samples: 1000)
Bias SE 95% CI P Value
Age >70 years 0.40 0.01 0.40 0.41 to 1.15 0.27
BMI >27 kg/m2† 0.72 0.02 0.38 0.02 to 1.43 0.03
eGFR <50 mL/min‡§ 1.11 0.09 0.39 0.43 to 1.99 <0.01
Dialysis 0.19 0.13 2.03 2.09 to 2.06 0.83
NYHA class IV 0.81 0.08 0.43 0.03 to 1.76 0.028
CCS class 4 0.27 0.02 0.67 1.22 to 1.54 0.63
Left ventricular ejection fraction, 30% to 50%§ 0.26 0.01 0.41 0.51 to 1.06 0.48
sPAP >55 mm Hg§ 1.24 0.21 1.10 2.77 to 0.36 0.013
Coronary artery disease 0.33 5.57 9.88 20.8 to 3.25 0.502
Previous cardiac surgery 0.41 0.01 0.52 0.60 to 1.41 0.41
Critical state§ 0.97 0.06 0.51 0.001 to 2.08 0.042
Length of the preop. hospital stay <10 days† 0.16 0.04 0.48 0.78 to 1.10 0.73
Urgent surgical priority§ 0.65 0.04 0.40 0.12 to 1.50 0.078
Combined CABG 0.28 5.59 9.89 2.84 to 21.5 0.55
Surgery on thoracic aorta 1.11 0.05 0.76 0.45 to 2.55 0.086
Prosthetic valve endocarditis 0.37 0.01 0.50 0.60 to 1.29 0.44
CABG indicates coronary artery bypass grafting; CCS indicates Canadian Cardiovascular Society; eGFR, estimated glomerular ﬁltration rate; EuroSCORE, European System for Cardiac
Operative Risk Evaluation; NYHA, New York Heart Association; preop., preoperative; ROC, receiver operating characteristic; sPAP, systolic pulmonary artery pressure.
*All variables with a P<0.1 by univariable analysis were included in the model.
†
The best discriminatory value for in-hospital mortality by ROC analysis.
‡
The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was used to estimate GFR.
§
The deﬁnitions and cut-off values are those used for the EuroSCORE II.5
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fungi and multidrug resistant Gram-negative bacteria.
Although 3 surgical features (urgent priority, combined
coronary surgery, and surgery on thoracic aorta) and 1
endocarditis-related feature (prosthetic valve endocarditis)
were found to be related (P<0.1) to in-hospital death by
univariable analysis, they were not conﬁrmed as risk factors
by multivariable analyses. Contrary to other previous risk
prediction models,4–7,14,16 the variable “prosthetic valve
endocarditis” was not found to be an independent risk factor
for postoperative in-hospital death in either of the AEPEI
scores. Our data do not provide any ﬁrm evidence to explain
this discrepancy. No intraoperative features were associated
with increased postoperative death, even when a composite
variable, such as large intracardiac destruction, was consid-
ered. In our opinion, this is a strong point of the AEPEI score.
Every practitioner is indeed well aware that results of
combined cardiac operations in critically ill patients and the
treatment of complex intracardiac lesions can be dependent
on the surgeon’s experience and expertise, which are both
difﬁcult to measure.
Despite the existence of some differences between the
Italian and French patients of the study, such as the
Table 12. The AEPEI Score, the Original Model: Contingency
Table for the Hosmer–Lemeshow Test for Logistic Regression
(n=161)
Group
Death Survival
TotalObserved Expected Observed Expected
1 1 0.8 21 21.2 22
2 0 0.2 3 2.8 3
3 5 5.0 76 76.0 81
4 3 1.7 10 11.3 13
5 1 2.7 14 12.3 15
6 4 4.1 12 11.9 16
7 7 6.6 4 4.4 11
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse.
Figure 2. External validation of the AEPEI score in a validation
sample of 161 patients: discriminatory power. AEPEI indicates
Association pour l’Etude et la Prevention de l’Endocadite Infec-
tieuse; AUC, area under the receiver-operating characteristic
curve.
Table 13. The AEPEI Score, the Alternate Model:
Contingency Table for the Hosmer–Lemeshow Test for
Logistic Regression (n=361)
Group
Death Survival
TotalObserved Expected Observed Expected
1 6 8.5 153 150.5 159
2 6 6.5 55 54.5 61
3 11 8.9 41 43.1 52
4 17 13.1 30 33.9 47
5 16 19.0 26 23.0 42
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse.
Figure 3. AEPEI score discriminatory power: the original
5-variable model vs the alternate 3-variable model. AEPEI
indicates Association pour l’Etude et la Prevention de l’Endocadite
Infectieuse; AUC, area under the receiver operating characteristic
curve.
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preoperative characteristics of patients, surgical data, and
endocarditis-related features, there was no signiﬁcant differ-
ence in the discriminatory power of the AEPEI score between
the 2 series of patients. Besides, the Italian series included
patients operated on between 2000 and 2015. This could
imply that the score works well even in populations of
patients with different rates of comorbidities from other
institutions, and operated on in different historical periods.
Obviously, these hypotheses remain to be veriﬁed by new
studies that take into consideration the impact on outcomes
of the use of different surgical methods, different rates of use
of surgical techniques, and different perioperative manage-
ment of patients.
Overall, the performance of the predictive models consid-
ered and derived from large populations of patients from
North America, that is, STS risk score for IE and OPR score,
was lower than the European models. This could stress the
concept that outcomes postsurgery for IE are inﬂuenced by
epidemiological features both of the patient and the involved
pathogen.
Study Limitations
The primary limitation of the present study was the small size
of the sample. Actually, because the study patients were only
361, it is not surprising that only 5 variables were signiﬁcant
upon multivariable modeling. There may be indeed insufﬁcient
power to determine higher dimensional models. However, this
is a problem common also to 2 other existing scoring systems
that are being used to predict early mortality postsurgery for
IE, namely the PALSUSE and the De Feo score,14,16 and more
Table 14. Bootstrap Analysis of the Logistic Regression Model From Which the Alternate Model of the AEPEI Score was
Generated*
Variable A
Bootstrap (No. of Samples: 1000)
Bias SE 95% CI P Value
Age >70 years 0.16 <0.001 0.47 0.81 to 1.05 0.7
BMI >27 kg/m2† 0.65 0.04 0.41 0.13 to 1.55 0.08
eGFR <50 mL/min‡,§ 1.16 0.14 0.41 0.49 to 2.13 <0.01
Dialysis 0.38 0.08 1.66 1.68 to 2.18 0.66
NYHA class IV 0.73 0.06 0.41 0.004 to 1.66 0.05
CCS class 4 0.18 0.01 0.74 1.40 to 1.53 0.8
Left ventricular ejection fraction,
30% to 50%§
0.25 0.01 0.47 0.75 to 1.14 0.54
Coronary artery disease 0.38 6.50 10.1 20.2 to 3.13 0.44
Previous cardiac surgery 0.26 0.01 0.57 0.82 to 1.44 0.6
Critical state§ 0.91 0.08 0.53 0.07 to 2.07 0.05
Length of the preop. hospital
stay <10 days†
0.06 0.05 0.44 0.76 to 0.99 0.89
Urgent surgical priority§ 0.59 0.01 0.44 0.25 to 1.42 0.14
Combined CABG 0.23 6.51 10.1 2.68 to 21.1 0.53
Surgery on thoracic aorta 0.94 0.01 0.76 0.70 to 2.41 0.13
Prosthetic valve endocarditis 0.37 <0.001 0.49 0.66 to 1.28 0.4
CABG indicates coronary artery bypass grafting; CCS indicates Canadian Cardiovascular Society; eGFR, estimated glomerular ﬁltration rate; EuroSCORE, European System for Cardiac
Operative Risk Evaluation; NYHA, New York Heart Association; preop., preoperative; ROC, receiver operating characteristic; sPAP, systolic pulmonary artery pressure.
*All variables with a P<0.1 by univariable analysis except sPAP >55 mm Hg were included in the model.
†
The best discriminatory value for in-hospital mortality by ROC analysis.
‡
The creatinine clearance rate, calculated according to the Cockcroft-Gault formula, was used to estimate GFR.
§
The deﬁnitions and cut-off values are those used for the EuroSCORE II.5
Table 15. The AEPEI Score, the Alternate Model:
Contingency Table for the Hosmer–Lemeshow Test for
Logistic Regression (n=161)
Group
Death Survival
TotalObserved Expected Observed Expected
1 10 9.0 110 111.0 120
2 1 3.1 21 18.9 22
3 10 8.9 9 10.1 19
AEPEI indicates Association pour l’Etude et la Prevention de l’Endocadite Infectieuse.
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generally to every predictive system of rare events occurring
in patients having rare diseases. Although the present authors
are aware that each score performs well in the data set in
which it is ﬁt, and the more-interesting comparison would be
of the various scores in the external validation sample, this
comparison was impossible because no other score than the
AEPEI could be calculated in the validation sample with the
available data. Because the pathogen was not identiﬁed in
about 18% of cases, there is the possibility that some
microorganisms were related to increased mortality rate
postsurgery, especially because some infections may have
been misclassiﬁed in terms of etiology because of the
frequent rate of coinfections in endocarditis. This study did
not evaluate the contribution to mortality risk of potentially
important factors, such as antibiotic treatment and preoper-
ative patient preparation. The impact of different strategies of
myocardial protection and techniques, such as intraoperative
ultraﬁltration, on the risk of death was not taken into account.
Conclusions
Nonspeciﬁc scoring systems derived from large populations of
patients are being used worldwide to predict adverse events
after cardiac surgery, even in patients with IE. For this difﬁcult
subset of patients, however, risk stratiﬁcation is of the utmost
importance not only to aid the surgeon’s decision making, but
also to ensure true informed consent for patients and their
family, and to allow comparative assessment of quality of
care. Speciﬁc and simple predictive systems, such as the
AEPEI score developed and validated here, could be useful to
achieve these objectives. However, further larger validation
studies are necessary before introducing the AEPEI score into
the clinical practice.
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Table S1. The variables entered in the analysis. 
Group Variable Cut-points and subsets 
Baseline characteristics of patients  
 
 
 
 
 
 
 
 
 
 
 
 
 
Age (years) 
Female sex 
Hypertension 
Current smoker 
Body mass index (kg/m2)  
Diabetes mellitus  
Anemia† 
White blood cell (103/mm3) 
C-reactive protein (mg/l) 
Poor mobility‡ 
Chronic lung disease‡ 
eGFR (ml/min)§ 
Dialysis 
Extracardiac arteriopathy‡ 
<60, 60–70, >70 
 
 
 
>27* 
Diabetes on insulin 
 
 
 
 
 
>85, 50–85, <50‡ 
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Surgical features 
 
 
 
 
NYHA class 
CCS class 
Recent myocardial infarction‡ 
Left ventricular ejection fraction (%) 
Pulmonary artery pressure, systolic (mmHg) 
Coronary artery disease 
Previous cardiac surgery 
Critical state‡ 
Length of the preoperative hospital stay (days) 
Era|| 
 
Reason for surgery 
 
 
 
 
I, II, III, IV 
4 
 
>50, 30–50, 20–30, <20‡ 
<35, 35–55, ≥55‡ 
 
 
 
>10* 
2000–2005, 2006–2010, 2011–2015 
 
Refractory heart failure due to valvular dysfunction 
Persistent infection 
Embolism (and recurrent embolism) 
Perivalvular complications# 
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Surgical priority‡ 
 
 
 
 
Valve involvement 
 
 
 
 
Large intracardiac destruction  
 
 
 
Weight of the intervention‡ 
 
Elective 
Urgent 
Emergency 
Salvage 
 
Aortic  
Mitral 
Tricuspid 
Multivalvular 
 
Extensive valve destruction 
Perivalvular complications 
Multivalvular involvement  
 
Combined CABG 
Single non-CABG 
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Endocarditis-related features 
 
 
 
 
Type of endocarditis 
 
 
 
 
Causal agents 
Two procedures 
Three procedures 
Surgery on thoracic aorta 
 
Active or treated‡ 
Native valve  
Prosthetic valve 
Intracardiac device or other side 
 
Streptococcus species 
Staphylococcus aureus 
Coaagulase-negative Staphylococci 
Enterococcus species 
Gram-negative bacteria  
Fungi 
Not identified 
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*The best discriminative value for hospital mortality by ROC analysis. 
†Defined as haemoglobin <12 g/dl for women and <13 g/dl for men. 
‡The definitions and the cut-points are those used for the EuroSCORE II (Suppl. Ref. 1).  
§The creatinine clearance rate, calculated according to the Cockcroft-Gault formula, was used to estimate eGFR.  
||Only the Italian study patients are considered for this analysis.  
#Perivalvular leak, annular or aortic abscess, sinus of Valsalva aneurysm, aortic fistula, and prosthetic valve detachment. 
 
CABG=coronary artery bypass grafting; CCS=Canadian Cardiovascular Society; EuroSCORE=European System for Cardiac Operative Risk Evaluation; 
eGFR=estimated glomerular filtration rate; NYHA=New York Heart Association; ROC=receiver-operating characteristic curve  
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Table S2. Baseline characteristics of patients (n=361)* 
Variable Total 
(n=361) 
In-hospital dead 
(n=56) 
Alive 
(n=305) 
p-Value 
Age (years) 
   <60 
   60–70 
   >70 
Female sex 
Hypertension 
Current smoker 
Body mass index (kg/m2) 
   >27† 
Diabetes 
   Diabetes on insulin 
Anemia‡ 
White blood cell (103/mm3) 
C-reactive protein (mg/l) 
Poor mobility§ 
Chronic lung disease§ 
eGFR (ml/min)|| 
   >85§ 
   50–85§ 
   <50§ 
Dialysis 
Extracardiac arteriopathy§ 
NYHA class 
59.1±15.4 
169 (46.8) 
97 (26.9) 
95 (26.3) 
76 (21.1) 
111 (30.7) 
65 (18.0) 
25.4±4.9 
95 (26.3) 
70 (19.4) 
27 (7.5) 
284 (81.7) 
14.9 ± 10.5 
140.4±85.5 
20 (5.5) 
33 (9.1) 
68.8±36.1 
99 (27.4) 
141 (39.1) 
121 (33.5) 
15 (4.2) 
50 (13.9) 
 
62.0±15.7 
16 (28.6) 
18 (32.1) 
22 (39.3) 
15 (26.8) 
18 (32.1) 
6 (10.7) 
26.7±5.8 
21 (37.5) 
10 (17.9) 
6 (10.7) 
50 (89.3) 
15.3 ± 6.7 
151.6±66.9 
5 (8.9) 
7 (12.5) 
47.1±31.2 
5 (8.9) 
14 (25.0) 
37 (66.1) 
5 (8.9) 
10 (17.9) 
 
58.6±15.3 
153 (50.2) 
79 (25.9) 
73 (23.9) 
61 (20.0) 
93 (30.5) 
59 (19.3) 
25.1±4.7 
74 (24.3) 
60 (19.7) 
21 (6.9) 
245 (80.3) 
14.8 ± 11.1 
138.4±88.4 
15 (4.9) 
26 (8.5) 
72.8±35.6 
94 (30.8) 
127 (41.6) 
84 (27.5) 
10 (3.3) 
40 (13.1) 
  
0.13 
 
 
 
0.25 
0.81 
0.12 
0.026 
0.039  
0.75 
0.32 
0.13 
0.75 
0.29 
0.23 
0.34 
<0.0001 
 
 
 
0.066 
0.35 
<0.0001 
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   I 
   II 
   III 
   IV 
CCS class 4 
Recent myocardial infarction§ 
Left ventricular ejection fraction (%) 
   >50§ 
   30–50§ 
   20–30§ 
   <20§ 
Pulmonary artery pressure, systolic 
(mmHg) 
   <35§ 
   35–55§ 
   >55§ 
Coronary artery disease 
Previous cardiac surgery 
Critical state§ 
Length of the preop. hospital stay 
(days)  
   <10† 
Era** 
   2000–2005 
   2006–2010 
   2011–2015 
105 (29.1) 
37 (10.2) 
83 (23) 
136 (37.7) 
23 (6.4) 
1 (0.3) 
56.6±3.5 
289 (80.1) 
67 (18.6) 
4 (1.1) 
1 (0.3) 
 
 
273 (75.6) 
70 (19.4) 
18 (5) 
43 (11.9) 
54 (15.0) 
62 (17.2) 
9 [3–25]# 
 
190 (52.6) 
 
40/138 (30) 
43/138(31.1) 
55/138 (39.9) 
7 (12.5) 
1 (1.8) 
14 (25.0) 
34 (60.7) 
8 (14.3) 
0  
54.6±12.1 
39 (69.6) 
16 (28.6) 
1 (1.8) 
0  
 
 
44 (78.6) 
6 (10.7) 
6 (10.7) 
11 (19.6) 
14 (25.0) 
23 (41.1) 
7 [4–16]# 
 
36 (64.3) 
 
7/28 (25) 
10/28 (35.7) 
11/28 (39.3) 
98 (32.1) 
36 (11.8) 
69 (22.6) 
102 (33.4) 
15 (4.9) 
1 (0.3) 
57.2±10.3 
250 (82.0) 
51 (16.7) 
3 (1) 
1 (0.3) 
 
 
229 (75.1) 
64 (21) 
12 (3.9) 
32 (10.5) 
40 (13.1) 
39 (12.8) 
10 [3–26]# 
 
154 (50.5) 
 
33/110 (30) 
33/110 (30) 
44/110 (40) 
 
 
 
 
0.015 
1 
0.29 
 
 
 
 
<0.0001 
 
 
 
 
0.052 
0.022 
<0.0001 
0.054 
 
0.061 
0.81 
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*Unless otherwise stated, values are mean ± standard deviation, or number (percentage).  
†The best discriminative value for in-hospital mortality by ROC analysis. 
‡Defined as haemoglobin <12 g/dl for women and <13 g/dl for men. 
§The definitions and the cut-off values are those used for the EuroSCORE II (Suppl. Ref. 1).  
||The creatinine clearance rate, calculated according to the Cockcroft-Gault formula, was used to estimate 
GFR.  
#Median [interquartile range]. 
**Only the Italian study patients are considered for this analysis. 
 
CCS=Canadian Cardiovascular Society; EuroSCORE=European System for Cardiac Operative Risk 
Evaluation; eGFR=estimated glomerular filtration rate; NYHA=New York Heart Association; 
ROC=receiver-operating characteristic curve  
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Table S3. Surgical features (n=361)* 
Variable Total 
(n=361) 
In-hospital dead 
(n=56) 
Alive 
(n=305) 
p-Value 
Reason for surgery 
   Refractory heart failure due to valvular 
dysfunction 
   Persistent infection 
   Embolism 
      Recurrent 
   Perivalvular complications† 
Surgical priority‡ 
   Elective 
   Urgent 
   Emergency 
   Salvage 
Valve involvement 
   Aortic 
   Mitral 
   Tricuspid 
   Multivalvular 
Large intracardiac destruction§ 
Weight of the intervention‡ 
   Combined CABG 
   Single non-CABG 
   Two procedures 
   Three procedures 
 
91 (25.2) 
 
46 (12.7) 
164 (45.4) 
53 (14.7) 
107 (29.6) 
 
133 (36.8) 
184 (51.0) 
33 (9.1) 
11 (3) 
 
224 (62.0) 
167 (46.3) 
35 (9.7) 
78 (21.6) 
175 (48.5) 
 
38 (10.5) 
215 (59.6) 
128 (35.5) 
18 (5.0) 
 
17 (30.4) 
 
6 (10.7) 
27 (48.2) 
11 (19.6) 
19 (33.9) 
 
10 (17.9) 
38 (67.9) 
7 (12.5) 
1 (1.8) 
 
34 (60.7) 
31 (55.4) 
4 (7.1) 
15 (26.8) 
32 (57.1) 
 
10 (17.9) 
28 (50.0) 
24 (42.9) 
4 (7.1) 
 
74 (24.3) 
 
40 (13.1) 
137 (44.9) 
42 (13.8) 
88 (28.9) 
 
123 (40.3) 
146 (47.9) 
26 (8.5) 
10 (3.3) 
 
190 (62.3) 
136 (44.6) 
31 (10.2) 
63 (20.7) 
143 (46.9) 
 
28 (9.2) 
187 (61.3) 
104 (34.1) 
14 (4.6) 
 
0.33 
 
0.62 
0.65 
0.25 
0.45 
<0.0001 
 
 
 
 
 
0.82 
0.14 
0.48 
0.31 
0.16 
 
0.052 
0.11 
0.21 
0.49 
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*Values are mean ± standard deviation, or number (percentage).  
†Perivalvular leak, annular or aortic abscess, sinus of Valsalva aneurysm, aortic fistula and prosthetic 
valve detachment. 
‡The definitions are those used for the EuroSCORE II (Suppl. Ref. 1).  
§Defined as extensive valve destruction, perivalvular complications or multivalvular involvement.   
 
CABG=coronary artery bypass grafting; EuroSCORE=European System for Cardiac Operative Risk 
Evaluation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Surgery on thoracic aorta 24 (6.6) 7 (12.5) 17 (5.6) 0.075 
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Table S4. Endocarditis-related features (n=361)* 
*Number (percentage).  
†The definitions are those used for the EuroSCORE II (Suppl. Ref. 1).  
 
EuroSCORE=European System for Cardiac Operative Risk Evaluation 
 
 
 
Variable Total 
(n=361) 
In-hospital dead 
(n=56) 
Alive 
(n=305) 
p-
Value 
Endocarditis 
   Active† 
   Treated† 
Type of endocarditis 
   Native valve 
   Prosthetic valve 
   Intracardiac device or other side 
Causal agents 
   Streptococcus species 
   Staphylococcus aureus 
   Coagulase-negative 
Staphylococci 
   Enterococcus 
   Gram-negative bacteria 
   Fungi 
   Not identified 
 
275 (76.2) 
86 (23.8) 
 
285 (78.9) 
68 (18.8) 
48 (13.3) 
 
134 (37.1) 
72 (19.9) 
33 (9.1) 
37 (10.2) 
15 (4.2) 
4 (1.1) 
66 (18.3) 
 
38 (67.9) 
18 (32.1) 
 
39 (69.6) 
16 (28.6) 
10 (17.9) 
 
13 (23.2) 
13 (23.2) 
8 (14.3) 
7 (12.5) 
2 (3.6) 
2 (3.6) 
11 (19.6) 
 
237 (77.7) 
68 (22.3) 
 
246 (80.7) 
52 (17) 
38 (12.5) 
 
121 (39.7) 
59 (19.3) 
25 (8.2) 
30 (9.8) 
13 (4.3) 
2 (0.7) 
55 (18) 
0.11 
 
 
 
0.063 
0.043 
0.27 
0.13 
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Supplemental Reference: 
1. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE 
II. Eur J Cardiothorac Surg. 2012;41:734-744. 
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